NEETPGAI
BlogPricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Subjects
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Help Center

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/PSM/Iron and Anemia
    Iron and Anemia
    medium
    users PSM

    A 28-year-old woman from rural Maharashtra presents with fatigue, dyspnea on exertion, and menorrhagia for 8 months. On examination: pallor, tachycardia (HR 102/min), no organomegaly. Hb 7.2 g/dL, MCV 68 fL, serum ferritin 12 ng/mL, serum iron 35 µg/dL, TIBC 420 µg/dL. What is the most appropriate next step in management?

    A. Start oral iron supplementation (ferrous sulfate 200 mg daily) and reassess in 4 weeks
    B. Refer to hematology for bone marrow biopsy before starting any treatment
    C. Perform upper and lower GI endoscopy to exclude occult bleeding
    D. Transfuse 2 units packed RBCs and then start iron therapy

    Explanation

    ## Clinical Assessment This patient has **iron deficiency anemia (IDA)** confirmed by: - Low Hb (7.2 g/dL) - Microcytic indices (MCV 68 fL) - Low serum ferritin (12 ng/mL) — most specific marker for depleted iron stores - Low serum iron with elevated TIBC — confirms iron deficiency - Clear source: menorrhagia in a reproductive-age woman ## Management Algorithm for Iron Deficiency Anemia ```mermaid flowchart TD A["Confirmed IDA with Hb > 7 g/dL"]:::outcome --> B{"Symptoms of high-output state?"}:::decision B -->|No| C["Oral iron therapy"]:::action B -->|Yes| D["Transfusion if Hb < 7 or symptomatic"]:::action C --> E["Recheck Hb in 4 weeks"]:::action E --> F{"Hb rise ≥ 1 g/dL?"}:::decision F -->|Yes| G["Continue iron, investigate cause"]:::action F -->|No| H["Check compliance, consider IV iron"]:::action D --> I["Then start oral iron"]:::action ``` ## Why Oral Iron Therapy Is First-Line **Key Point:** In a non-bleeding, hemodynamically stable patient with Hb > 7 g/dL, oral iron is the standard initial therapy — it is cost-effective, safe, and allows assessment of compliance and absorption. **High-Yield:** The "4-week rule" — if Hb rises by ≥ 1 g/dL in 4 weeks on oral iron, IDA is confirmed and the diagnosis is secure. This response also guides further workup for the cause (menorrhagia vs. GI loss). **Clinical Pearl:** Menorrhagia is the most common cause of IDA in reproductive-age women in India; GI investigation is indicated only if: - No response to oral iron after 4–6 weeks (suggests poor absorption or ongoing GI loss) - Age > 40 years - Male gender - Alarm symptoms (dysphagia, weight loss, melena) ## Dosing & Monitoring | Parameter | Details | |-----------|----------| | **First-line agent** | Ferrous sulfate 200 mg daily (or ferrous fumarate 325 mg) | | **Absorption** | Best on empty stomach; take with vitamin C | | **Expected Hb rise** | 1–2 g/dL per month | | **Recheck timing** | 4 weeks (assess response) | | **Duration** | Continue 3–6 months after Hb normalizes (replete stores) | **Tip:** Counsel on side effects (GI upset, black stools) to improve compliance — the most common reason for "failure" of oral iron is non-adherence, not malabsorption. [cite:Park 26e Ch 8] ![Iron and Anemia diagram](https://mmcphlazjonnzmdysowq.supabase.co/storage/v1/object/public/blog-images/explanation/16373.webp)

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More PSM Questions